Aclaris Therapeutics, Inc. (ACRS)

Aclaris Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	47.65	39.88	45.28	27.35	22.06	34.19
Short-Term Investments	80.07	79.23	172.29	164.07	32.07	39.08
Cash & Short-Term Investments	127.72	119.11	217.57	191.41	54.13	73.27
Cash Growth	23.94%	-45.26%	13.67%	253.61%	-26.12%	-56.38%
Receivables	0.34	0.3	0.48	0.62	0.77	0.7
Prepaid Expenses	4.27	9.45	13.5	13	2.59	3.12
Restricted Cash	-	-	-	-	-	1.75
Other Current Assets	-	-	-	-	-	4.97
Total Current Assets	132.33	128.86	231.55	205.03	57.49	83.8
Property, Plant & Equipment	4.11	5.48	3.78	4.77	5.78	7.2
Long-Term Investments	45.71	62.77	12.24	34.24	-	-
Other Intangible Assets	-	0.27	6.97	7.05	7.12	7.2
Other Long-Term Assets	0.24	0.03	0.05	0.12	0.39	0.09
Total Assets	182.39	197.41	254.6	251.21	70.78	98.3
Accounts Payable	7.66	8.88	10.35	9.99	5.25	9.92
Accrued Expenses	3.14	10.86	8.2	7.37	5.91	7.72
Current Portion of Leases	-	0.43	0.68	0.72	0.6	0.64
Other Current Liabilities	4.25	10.79	2.7	4.85	3.11	4.16
Total Current Liabilities	18.82	30.95	21.94	22.93	14.87	22.43
Long-Term Debt	-	-	-	-	10.65	-
Long-Term Leases	2.25	3.07	1.57	2.17	2.89	3.57
Long-Term Deferred Tax Liabilities	-	-	0.37	0.37	0.37	0.55
Other Long-Term Liabilities	10	6.2	33.1	28.4	4.35	1.84
Total Liabilities	52.24	40.23	56.98	53.87	33.13	28.39
Common Stock	0	0	0	0	-	-
Additional Paid-In Capital	936.03	928.08	880.83	792.97	542.29	523.51
Retained Earnings	-806.31	-770.8	-682.32	-595.41	-504.54	-453.53
Comprehensive Income & Other	0.43	-0.11	-0.9	-0.22	-0.09	-0.07
Total Common Equity	130.15	157.18	197.62	197.34	37.65	69.91
Shareholders' Equity	130.15	157.18	197.62	197.34	37.65	69.91
Total Liabilities & Equity	182.39	197.41	254.6	251.21	70.78	98.3
Total Debt	2.25	3.5	2.25	2.89	14.15	4.21
Net Cash (Debt)	171.19	178.38	227.56	222.76	39.98	69.06
Net Cash Growth	-7.39%	-21.61%	2.15%	457.17%	-42.11%	-49.93%
Net Cash Per Share	2.41	2.56	3.49	3.93	0.94	1.67
Filing Date Shares Outstanding	71.43	70.93	66.69	61.28	51.8	41.53
Total Common Shares Outstanding	71.42	70.89	66.69	61.23	45.11	41.49
Working Capital	113.51	97.9	209.61	182.1	42.62	61.37
Book Value Per Share	1.82	2.22	2.96	3.22	0.83	1.69
Tangible Book Value	130.15	156.91	190.65	190.29	30.53	62.71
Tangible Book Value Per Share	1.82	2.21	2.86	3.11	0.68	1.51
Machinery	5	4.97	4.01	3.61	3.15	3.21
Leasehold Improvements	0.82	0.82	1.12	1.12	1.12	0.89

Source: S&P Capital IQ. Standard template. Financial Sources.